[an error occurred while processing this directive]
|CANCER & TREATMENTS FOR CANCER CENTER PATIENTS PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER|
REDMAN JOINS U-M CANCER CENTER TO HEAD CLINICAL TRIALS EFFORTOriginally posted August 4, 1997
Ann Arbor, Mich. -- Bruce G. Redman, D.O., has been appointed associate professor of internal medicine and director of the clinical trials program at the University of Michigan Comprehensive Cancer Center.
A leading expert in prostate cancer, renal cell carcinoma and melanoma, Redman previously served as director of the genitourinary oncology program at the Barbara Ann Karmanos Cancer Institute in Detroit.
"Dr. Redman is an outstanding clinician and clinical investigator, who will add significantly to our efforts in developing immunotherapies for cancer patients," says U-M Cancer Center director Max S. Wicha, M.D. "He also will play a major leadership role in the Cancer Center as director of the clinical trials office, which facilitates our clinical research. We are truly delighted to have Dr. Redman join the Cancer Center team."
Redman brings extensive experience in the clinical application of biological response modifiers (naturally or artificially produced agents, such as interferon, that boost the body's immune system). He will be active in the U-M's gene therapy and tumor immunology programs.
"I joined the University of Michigan Cancer Center because of the cutting-edge research underway here, and I look forward to continuing to build the U-M's clinical program," says Redman. "My primary focus will be to work with researchers to speed the transfer of scientific findings to the clinical setting where they can benefit patients."
Redman will also lead one of the Cancer Center's six clinical teams, overseeing patient care activities in the breast, head and neck, sarcoma, and melanoma clinics.
"Dr. Redman exemplifies all that a modern cancer clinician should be," says Laurence H. Baker, U-M Cancer Center deputy director and former director of the Meyer L. Prentis Cancer Center (now Karmanos Institute). "He's compassionate, thorough and highly knowledgeable."
Redman received his medical degree at the Chicago College of Osteopathic Medicine and completed his oncology fellowship at Wayne State University in Detroit.
A leader in patient care, education, research and community outreach, the University of Michigan Comprehensive Cancer Center was established in 1986 and is one of only 26 National Cancer Institute-designated comprehensive cancer centers in the country.
This article is from a publication now a part of the Cancer Center's News Archive. It
is listed here for historical purposes only.